Latest Research
A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-inflammatory activity. Nat. Comm. October 2023
Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritis. Ann Rheum Dis. September 2023
Research Group of Stephan Blüml
In our group, we analyze the mechanisms leading to joint inflammation and subsequently joint destruction, with an emphasis on the contribution of myeloid cells in that process.
Research Group of Michael Bonelli
The main interest of our laboratory is to understand the exact mechanisms that are important for cell stability and identity in T cell-mediated autoimmune diseases such as Systemic Lupus Erythematosus or Rheumatoid Arthritis.
Research Group of Thomas Karonitsch
Our group aims to unfold the mechanisms that drive FLS activation in inflammatory joint diseases. We focus on inflammatory and metabolic pathways (e.g. mTOR pathway) that are critical for the inflammatory response in FLS.